According to IMARC Group’s latest research report, titled “Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the heparin market share. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global heparin market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028.
Heparin Market Overview:
Heparin is a vital anticoagulant medication widely used in the medical field to prevent blood clots. It is a naturally occurring substance that belongs to the family of glycosaminoglycans and is primarily derived from animal sources, such as porcine intestine or bovine lung. It is composed of chains of polysaccharide molecules, specifically repeating units of glucuronic acid and N-acetylglucosamine. These molecules interact with antithrombin III, a protein present in the blood, to inhibit the formation of blood clots. Due to its ability to prevent clotting, heparin plays an important role in various medical applications, including surgeries, dialysis procedures, and the treatment of deep vein thrombosis and pulmonary embolism. Currently, unfractionated heparin (UFH) and low molecular weight heparin (LMWH) are some of the commonly available product variants.
Get Sample Copy of Report at – https://www.imarcgroup.com/heparin-market/requestsample
Global Heparin Market Trends:
The escalating prevalence of cardiovascular diseases and the rising geriatric population are some of the primary factors supporting the market growth. Furthermore, the expansion of surgical procedures has necessitated the use of anticoagulants, such as heparin, to prevent postoperative complications, which is providing an impetus to the market growth. Apart from this, the growing incidence of chronic diseases, including cancer and renal disorders, and the ongoing advancements in the pharmaceutical industry, particularly in the field of drug delivery systems and formulations, have led to the development of novel heparin-based products, which are creating a positive outlook for the market. In line with this, key manufacturers are introducing new and improved formulations, such as extended-release or targeted delivery systems, to increase their product portfolio, which is augmenting the market growth.
Key Market Segmentation:
Top Heparin Companies Worldwide:
- GlaxoSmithKline
- Hepalink
- Pfizer
- LeoPharma
- Sanofi
- Reddy’s Laboratories
- Teva Pharmaceutical Industries
- Aspen
- LEO Pharma
- Baxter
- Changshan Pharm
- Sandoz
- Opocrin
- Deebio
- Tiandong
Market Breakup by Product:
- Unfractionated Heparin
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMWH)
Market Breakup by Source:
- Bovine
- Porcine
Market Breakup by Mode of Administration:
- Oral
- Parenteral
Market Breakup by Application:
- Atrial Fibrillation & Heart Attack
- Stroke
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Others
Market Breakup by End-User:
- Hospitals
- Clinics
- Homecare Settings
- Ambulatory Surgical Centers
- Others
Market Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Stores
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
